European VC Directory

Venture capital firm investing in high-growth technology companies.

Glenfarne Group LLC

Washington, DC, US

Glenfarne Group invests in and operates specialized energy transition assets, including renewables (solar, hydro), grid stability solutions, and midstream infrastructure. The firm provides operational and strategic support to scale assets into profitable businesses, with a geographic focus on Latin America, Southeast Asia, and North America.

Global BioAccess Fund partners with forward-thinking companies to create new medicines by investing in transformative technologies that address unmet needs in Oncology, I&I (Immunology & Inflammation), Cardiovascular, CNS (Central Nervous System), and rare diseases. They focus on early-stage companies needing capital to support IND (Investigational New Drug) submission and clinical trials. Their team and network of scientific and industry leaders offer broad and deep expertise and resources. With every interaction, they strive to deliver excellence to patients, entrepreneurs, and investors. The fund's investment strategy appears to be centered around identifying and funding companies with novel therapeutics and devices that can address significant unmet medical needs. They provide capital to support crucial stages of drug development like IND submission and early-stage clinical trials, thereby enabling companies to advance their innovative solutions. They aim to accelerate the development of innovative science to create new medicines. Given the portfolio, the fund seems open to investing in varied modalities of therapeutics, including cell therapies, small molecule drugs, and immunotherapies. They look for novel mechanisms and targets within the therapeutic areas they invest. The firm seems willing to invest internationally as reflected by its portfolio companies based in Europe and across the US. The fund's stated commitment to delivering excellence to patients, entrepreneurs, and investors suggests a collaborative and patient-centric approach. They strive to build long-term relationships with their portfolio companies and contribute to the advancement of medical science by backing innovative companies and technologies.

Global Brain Corp.

JP

Global Brain is an independent venture capital firm committed to fostering new industries through robust, hands-on support for startups and promoting open innovation with large corporations. The firm actively invests in over 100 startups annually, demonstrating a high level of global engagement. They aim to help startups achieve global scale by providing not only capital, but also strategic guidance and resources to navigate international markets. They seek to identify and support companies with disruptive technologies and innovative business models that can address significant societal needs and create new market opportunities. Their investment approach emphasizes a collaborative relationship with portfolio companies, offering tailored support that goes beyond traditional financial investment. This includes access to their extensive network of industry experts, corporate partners, and potential customers. Global Brain's strategy also incorporates open innovation initiatives, facilitating partnerships between startups and established corporations to accelerate technology adoption and market entry. By combining financial backing with strategic collaboration, Global Brain aims to maximize the potential of its portfolio companies and drive industry transformation. Global Brain's commitment is evidenced by their substantial Assets Under Management (AUM) and active investment portfolio. Their track record includes significant exits through IPOs and M&A, highlighting their ability to identify and nurture successful startups. The firm is particularly interested in supporting startups that demonstrate a strong potential for growth and a clear path to achieving significant market impact. Their focus extends beyond financial returns, as they actively seek to contribute to the development of innovative solutions that benefit society as a whole. They focus on both Japanese and international startups.

Global Brain Corporation

JP

Global Brain is an independent venture capital firm with a mission to foster the creation of new industries by providing extensive hands-on support to startups and promoting open innovation with large corporations. They aim to help startups achieve global scalability and success. They achieve this through a combination of strategic investments, active portfolio management, and leveraging their network to connect startups with resources and opportunities. The firm's investment strategy focuses on identifying and supporting innovative companies that have the potential to disrupt existing markets or create entirely new ones. Global Brain seeks out ventures with strong founding teams, differentiated technologies or business models, and a clear path to sustainable growth. Their approach includes active involvement in portfolio companies, providing mentorship, guidance, and access to their extensive network of industry experts and partners. Global Brain actively participates in open innovation initiatives, collaborating with large corporations to identify promising startups and facilitate partnerships that can accelerate innovation and drive business growth. This collaborative approach allows them to bring new technologies and solutions to market more quickly and efficiently. They have a long track record of successful investments, exits (IPOs and M&As), and a demonstrated ability to identify and nurture high-growth companies. Their investment pace is aggressive, investing in more than 100 startups every year. With a strong presence in Japan, they are also expanding their global reach through investments in other key markets. They also invest in companies that are on the path to IPO on the TSE Growth Market (like Mirrativ).

Backs exceptional founders in fast-growing technology companies across diverse sectors, supporting them from early-stage investment with a global perspective.

Venture capital firm investing in high-growth technology companies.

Global Innovation Fund

GB

Global Innovation Fund (GIF) is an impact-focused investment firm that provides financial investment and strategic, post-investment support to accelerate growth and maximize impact for underserved communities. They combine financial investment with strategic, post-investment support to accelerate growth and maximise impact. GIF deploys flexible capital, utilizing grants, equity, and debt, to support early-stage innovations with proven potential to transform lives and progress toward scale. They de-risk and nurture high-potential innovations by providing deep technical, financial, and advisory support, along with connections to a powerful network of peer innovators and follow-on funders. GIF is committed to generating actionable insights and learnings that help innovators, partners, and the wider ecosystem learn, adapt, and make better decisions. The fund strategically prioritizes investments in Africa and Asia, focusing resources where the potential and need for scalable and sustainable change is greatest. GIF seeks innovations driving solutions across two critical thematic areas: building climate resilience and unlocking inclusive economic opportunities. GIF measures its impact by the amount of additional capital attracted to their innovations per dollar invested, the number of people expected to benefit, and the net social value created by their investments. For example, they report $8 in additional capital attracted per $1 invested, 157 million people expected to benefit by 2034, and $1.15 billion in net social value created by five of their earliest investments. GIF Growth offers a specific debt investment option, as demonstrated by their investment in 4G Capital, enabling the company to scale credit to both new and existing clients. By supporting on-lending to 4G Capital’s customer base, this investment promotes financial inclusion for GIF’s target beneficiaries, particularly underserved micro and small enterprises.

Venture capital firm investing in high-growth technology companies.

Venture capital firm investing in high-growth technology companies.

Venture capital firm investing in high-growth technology companies.

Global Resilience Innovation Fund

Luxembourg, LU

Invests in startups developing resilient solutions to geopolitical, cyber, and climate-related threats across NATO and allied nations, leveraging deep expertise in defence, security, and disaster preparedness.

Venture capital firm investing in high-growth technology companies.

Venture capital firm investing in high-growth technology companies.

GG Ventures focuses on backing AI-driven companies that address the unique biological, health, and performance needs of women. The fund targets sectors like sports/wellness, longevity, cancer diagnostics, mental health, and reproductive health, emphasizing precision tools and proprietary data tailored to women rather than retrofitted male-centric solutions.

Goldacre

GB

Goldacre invests in digital infrastructure, particularly data centers, leveraging hands-on expertise to deliver exceptional returns. The firm specializes in building, owning, operating, and managing critical digital infrastructure assets, combining deep market knowledge and established networks to identify transformative opportunities in real estate and technology.

Golden Egg Check

DE

Golden Egg Check invests in the best early-stage founders in frontier AI, software, and deeptech, supporting them from founder community to venture capital fund.

Venture capital firm investing in high-growth technology companies.

Golden Vision Capital

Singapore, SG

A MAS-registered fund management company investing in private equity, venture capital, and private credit funds globally, anchored by a leading Asian Single Family Office.

GoldenTree Asset Management

New York, US

Based on the crawled pages, GoldenTree Asset Management LP primarily focuses on asset management and investment advisory services. Their offerings are targeted towards accredited investors, dealing in securities and interests in investment funds they manage. They invest in structured product portfolios, such as CLOs, and managed funds and accounts that have "private equity" type terms. Their website explicitly states that it does not constitute an offer to sell or solicit an offer to buy securities, and offerings are made only through prospectuses or private offering memoranda. Their investment strategies involve leveraging assets and committed capital within investment periods. While they don't explicitly define a specific investment thesis in the traditional venture capital sense, their approach is rooted in managing assets, especially in the structured credit and private equity domains, with a focus on maximizing returns within the bounds of accredited investor frameworks and relevant securities regulations.

Venture capital firm investing in high-growth technology companies.

Venture capital firm investing in high-growth technology companies.

Venture capital firm investing in high-growth technology companies.

Venture capital firm investing in high-growth technology companies.